311 related articles for article (PubMed ID: 23708831)
1. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.
Peng H; Wang W; Zhou M; Li R; Pan HF; Ye DQ
Clin Rheumatol; 2013 Sep; 32(9):1255-66. PubMed ID: 23708831
[TBL] [Abstract][Full Text] [Related]
2. Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus.
Wang T; Mei Y; Li Z
Biomed Res Int; 2019; 2019():7948687. PubMed ID: 31240224
[TBL] [Abstract][Full Text] [Related]
3. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus.
Cross JT; Benton HP
Inflamm Res; 1999 May; 48(5):255-61. PubMed ID: 10391113
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus.
Sarra M; Monteleone G
J Biomed Biotechnol; 2010; 2010():294582. PubMed ID: 20652041
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.
Llorente L; Zou W; Levy Y; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Morel-Fourrier B; Brouet JC; Alarcon-Segovia D; Galanaud P; Emilie D
J Exp Med; 1995 Mar; 181(3):839-44. PubMed ID: 7869046
[TBL] [Abstract][Full Text] [Related]
6. The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus.
Davis LS; Hutcheson J; Mohan C
J Interferon Cytokine Res; 2011 Oct; 31(10):781-9. PubMed ID: 21787222
[TBL] [Abstract][Full Text] [Related]
7. Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus.
Sim JH; Kim HR; Chang SH; Kim IJ; Lipsky PE; Lee J
Arthritis Res Ther; 2015 Jul; 17(1):190. PubMed ID: 26209442
[TBL] [Abstract][Full Text] [Related]
8. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).
Beebe AM; Cua DJ; de Waal Malefyt R
Cytokine Growth Factor Rev; 2002; 13(4-5):403-12. PubMed ID: 12220553
[TBL] [Abstract][Full Text] [Related]
9. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.
Geginat J; Vasco M; Gerosa M; Tas SW; Pagani M; Grassi F; Flavell RA; Meroni P; Abrignani S
Semin Immunol; 2019 Aug; 44():101330. PubMed ID: 31735515
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 and lupus: enough to be a target? For which patients?
Robert M; Miossec P
Lupus; 2020 Jan; 29(1):6-14. PubMed ID: 31791181
[TBL] [Abstract][Full Text] [Related]
11. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6
Facciotti F; Larghi P; Bosotti R; Vasco C; Gagliani N; Cordiglieri C; Mazzara S; Ranzani V; Rottoli E; Curti S; Penatti A; Karnani B; Kobayashi Y; Crosti M; Bombaci M; van Hamburg JP; Rossetti G; Gualtierotti R; Gerosa M; Gatti S; Torretta S; Pignataro L; Tas SW; Abrignani S; Pagani M; Grassi F; Meroni PL; Flavell RA; Geginat J
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7305-7316. PubMed ID: 32184325
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.
Yuan W; DiMartino SJ; Redecha PB; Ivashkiv LB; Salmon JE
Arthritis Rheum; 2011 Jan; 63(1):212-8. PubMed ID: 20954190
[TBL] [Abstract][Full Text] [Related]
14. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.
Cui HD; Qi ZM; Yang LL; Qi L; Zhang N; Zhang XL; Du SY; Jiang Y
Clin Exp Immunol; 2011 Aug; 165(2):163-71. PubMed ID: 21635228
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
17. [Immunometabolism and systemic lupus erythematosus].
Xiao YB; Guo MY; Zuo XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of tissue injury in lupus nephritis.
Nowling TK; Gilkeson GS
Arthritis Res Ther; 2011; 13(6):250. PubMed ID: 22192660
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus.
Birner P; Heider S; Petzelbauer P; Wolf P; Kornauth C; Kuroll M; Merkel O; Steiner G; Kishimoto T; Rose-John S; Soleiman A; Moriggl R; Kenner L
Exp Dermatol; 2016 Apr; 25(4):305-10. PubMed ID: 26739431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
